&l;p&g;It&s;s funny, in a way. Warren Buffett and Elon Musk are having a go at each other. It case you missed it, here&s;s what happened.
&l;img class=&q;dam-image getty size-large wp-image-930533880&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/930533880/960×0.jpg?fit=scale&q; data-height=&q;698&q; data-width=&q;960&q;&g; AUSTIN, TX – MARCH 11: Elon Musk speaks onstage at Elon Musk Answers Your Questions! during SXSW at ACL Live on March 11, 2018 in Austin, Texas. (Photo by Chris Saucedo/Getty Images for SXSW)
In a conference call last week, Musk quipped that &q;moats are lame.&q; He was referring to an expression used by Buffett to describe a company&s;s competitive advantage.
Moats come in many forms. They range from patents to secret formulas to brand recognition to distribution networks. I guess all of those things are lame in Musk&s;s world.
Musk explained his criticism of a term coined by Buffett in 1999: &q;&l;span&g;If your only defense against invading armies is a moat, you will not last long. What matters is the pace of innovation &a;mdash; that is the fundamental determinant of competitiveness.&a;rdquo;&l;/span&g;
Top Warren Buffett Stocks To Own For 2019: Enerplus Corporation(ERF)
- [By Ethan Ryder]
Enerplus (NYSE:ERF) (TSE:ERF) – Stock analysts at National Bank Financial reduced their FY2018 earnings estimates for Enerplus in a research note issued on Thursday, May 3rd. National Bank Financial analyst T. Wood now forecasts that the oil and natural gas company will earn $1.13 per share for the year, down from their previous estimate of $1.27. National Bank Financial also issued estimates for Enerplus’ FY2019 earnings at $1.96 EPS.
Top Warren Buffett Stocks To Own For 2019: Intercept Pharmaceuticals, Inc.(ICPT)
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
Top Warren Buffett Stocks To Own For 2019: Transglobe Energy Corp(TGA)
- [By Max Byerly]
Atlas Energy Group (OTCMKTS: ATLS) and Transglobe Energy (NASDAQ:TGA) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Top Warren Buffett Stocks To Own For 2019: Sunoco LP(SUN)
- [By Matthew DiLallo]
The only segment where earnings declined was the catch-all one labeled “all other,” which houses different investments such as its stake in Sunoco L.P. (NYSE:SUN) and PES, a refining joint venture. PES has struggled due to higher costs, and recently declared bankruptcy. Meanwhile, Energy Transfer’s earnings from Sunoco L.P. declined because that entity sold the bulk of its retail assets and then used that cash to repurchase a portion of Energy Transfer’s investment.
- [By Joseph Griffin]
Sunoco (NYSE:SUN) released its quarterly earnings results on Wednesday. The oil and gas company reported ($3.74) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($4.31), Briefing.com reports. Sunoco had a return on equity of 17.06% and a net margin of 1.27%. The firm had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. The firm’s revenue for the quarter was up 33.5% compared to the same quarter last year.
- [By Matthew DiLallo]
However, he did rule out the possibility that the company would also roll up its other MLP Sunoco LP (NYSE:SUN). He said that “we’re very pleased with what we’re seeing at SUN as far as the growth that they will be directing that MLP into. And as you know, SUN is younger in the IDR life.” Because of that “for the reasonable future, we don’t see that being rolled up.”
- [By ]
That’s the case for Sunoco (NYSE: SUN). After posting a net loss of $0.09 per share in 2017, the gas station owner is expected to swing to a hefty profit of $2.35 per share in 2018. But of the 14 analysts who follow the company, earnings estimates range as low as $1.22 and as high as $3.35 — so there is a high degree of uncertainty.